A multimillion-dollar pharmacy redevelopment project has kicked off at Tasmania's Royal Hobart Hospital (RHH) to deliver a state-of-the-art hospital pharmacy, including sterile pharmaceutical production facilities.
The Tasmanian Rockliff Liberal Government's RHH Pharmacy Redevelopment Project, part of a long-term plan to build a better health system across the state, includes purpose-built dispensary and sterile production suites.
The pharmacy, which will be constructed on the site of the existing statewide pharmacy and expand into the former Central Sterilising area, will also house Therapeutic Goods Administration accredited manufacturing facilities for jack jumper immunotherapy products for people with jack jumper ant venom allergies.
Hutchinson Builders have now begun site clearing and enabling works on the project, which is expected to reach completion in mid-2025.
"The Royal Hobart Hospital Pharmacy plays a critical role in delivering healthcare to inpatients and outpatients and supporting local and statewide pharmacy services," Minister for Health, Guy Barnett, commented.
"This pharmacy redevelopment will mean that our hardworking health staff can provide better care, right throughout the hospital, particularly for patients undergoing cancer treatment and patients receiving adult and neonatal intensive care.
"We are also continuing with our innovative approach to healthcare by building new dispensing facilities and clinical support areas, which means the RHH will be able to manufacture products right here in Tasmania," he added.
The Tas Govt first announced the RHH hospital redevelopment in 2019, at the time allocating a much smaller funding pool of $3.8 million (PD 28 May 2019). JM
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Dec 23
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Dec 23
